Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Infection
Published in: Infection 4/2017

01-08-2017 | Case Report

A dangerous hobby? Erysipelothrix rhusiopathiae bacteremia most probably acquired from freshwater aquarium fish handling

Authors: E. Asimaki, O. Nolte, G. Overesch, C. Strahm

Published in: Infection | Issue 4/2017

Login to get access

Abstract

Erysipelothrix rhusiopathiae is a facultative anaerobic Gram-positive rod that occurs widely in nature and is best known in veterinary medicine for causing swine erysipelas. In humans, infections are rare and mainly considered as occupationally acquired zoonosis. A case of E. rhusiopathiae bacteremia most likely associated with home freshwater aquarium handling is reported. The route of transmission was probably a cut with the dorsal fin of a dead pet fish. A short review of clinical presentations, therapeutic considerations and pitfalls of E. rhusiopathiae infections in humans is presented.
Literature
1.
Gorby GL, Peacock JE Jr. Erysipelothrix rhusiopathiae endocarditis: microbiologic, epidemiologic, and clinical features of an occupational disease. Rev Infect Dis. 1988;10:317–25.CrossRefPubMed
2.
3.
4.
Reboli AC. Erysipelothrix rhusiopathiae. In: Bennett JE, Dolin R, Blaser MJ, editors. Mandell, Douglas, and Bennett’s. Principles and practice of infectious diseases. 8th ed. Philadelphia, PA: Elsevier/Saunders; 2015. p. 2415–17.
5.
Stevens DL, Bisno AL, Chambers HF, Dellinger EP, Goldstein EJ, Gorbach SL, Hirschmann JV, Kaplan SL, Montoya JG, Wade JC, Infectious Diseases Society of A. Practice guidelines for the diagnosis and management of skin and soft tissue infections: 2014 update by the Infectious Diseases Society of America. Clin Infect Dis. 2014;59:e10–52. doi:10.​1093/​cid/​ciu444.CrossRef
6.
7.
8.
9.
Bleeker-Rovers CP, Vos FJ, de Kleijn EM, Mudde AH, Dofferhoff TS, Richter C, Smilde TJ, Krabbe PF, Oyen WJ, van der Meer JW. A prospective multicenter study on fever of unknown origin: the yield of a structured diagnostic protocol. Medicine (Baltimore). 2007;86:26–38. doi:10.​1097/​MD.​0b013e31802fe858​.CrossRef
10.
Principe L, Bracco S, Mauri C, Tonolo S, Pini B, Luzzaro F. Erysipelothrix Rhusiopathiae bacteremia without endocarditis: rapid identification from positive blood culture by MALDI-TOF mass spectrometry. A case report and literature review. Infect Dis Rep. 2016;8:6368. doi:10.​4081/​idr.​2016.​6368.CrossRefPubMedPubMedCentral
11.
Olsson DS, Andersson E, Bryngelsson IL, Nilsson AG, Johannsson G. Excess mortality and morbidity in patients with craniopharyngioma, especially in patients with childhood onset: a population-based study in Sweden. J Clin Endocrinol Metab. 2015;100:467–74. doi:10.​1210/​jc.​2014-3525.CrossRefPubMed
12.
Stuck AE, Minder CE, Frey FJ. Risk of infectious complications in patients taking glucocorticosteroids. Rev Infect Dis. 1989;11:954–63.CrossRefPubMed
13.
Xu CW, Zhang AY, Yang CM, Pan Y, Guan ZB, Lei CW, Peng LY, Li QZ, Wang HN. First report of macrolide resistance gene erm(T) harbored by a novel small plasmid from Erysipelothrix rhusiopathiae. Antimicrob Agent Chemother. 2015;59:2462–5. doi:10.​1128/​AAC.​00228-15.CrossRef
14.
15.
16.
Wong RC, Kong KO, Lin RV, Barkham T. Chronic monoarthritis of the knee in systemic lupus erythematosus. Lupus. 2003;12:324–6.CrossRefPubMed
17.
Forde T, Biek R, Zadoks R, Workentine ML, De Buck J, Kutz S, Opriessnig T, Trewby H, van der Meer F, Orsel K. Genomic analysis of the multi-host pathogen Erysipelothrix rhusiopathiae reveals extensive recombination as well as the existence of three generalist clades with wide geographic distribution. BMC Genom. 2016;17:461. doi:10.​1186/​s12864-016-2643-0.CrossRef
18.
Upapan P, Chayakulkeeree M. Erysipelothrix rhusiopathiae bacteremia without endocarditis associated with psoas abscess: the first case report in Thailand. J Med Assoc Thai. 2014;97:S232–6.PubMed
19.
20.
21.
Sheng WH, Hsueh PR, Hung CC, Fang CT, Chang SC, Luh KT. Fatal outcome of Erysipelothrix rhusiopathiae bacteremia in a patient with oropharyngeal cancer. J Formos Med Assoc. 2000;99:431–4.PubMed
22.
Volard B, Mignot L, Piednoir E, de Champs C, Limelette A, Guillard T. Systemic Erysipelothrix rhusiopathiae infection not associated with endocarditis highlighting bacteriological diagnosis difficulties: case report and literature review. Ann Biol Clin (Paris). 2016;74:306–12. doi:10.​1684/​abc.​2016.​1140.
23.
Surrun SK, Jaufeerally FR, Sim HC. Erysipelothrix rhuseopathiae septicaemia with prolonged hypotension: a case report. Ann Acad Med Singap. 2008;37:251–2.PubMed
Metadata
Title
A dangerous hobby? Erysipelothrix rhusiopathiae bacteremia most probably acquired from freshwater aquarium fish handling
Authors
E. Asimaki
O. Nolte
G. Overesch
C. Strahm
Publication date
01-08-2017
Publisher
Springer Berlin Heidelberg
Published in
Infection / Issue 4/2017
Print ISSN: 0300-8126
Electronic ISSN: 1439-0973
DOI
https://doi.org/10.1007/s15010-016-0966-z

Other articles of this Issue 4/2017

Infection 4/2017 Go to the issue

Original Paper

Correlation between antibiotic consumption and resistance of bloodstream bacteria in a University Hospital in North Eastern Italy, 2008–2014

Images in Infection

Pulmonary Echinococcus granulosus infection

Review

A review of infectious complications after haploidentical hematopoietic stem cell transplantations

Original Paper

Pulmonary mucormycosis: clinical features and outcomes

Original Paper

Good tolerability of high dose colistin-based therapy in patients with haematological malignancies

Original Paper

Efficacy and tolerability of switching to a dual therapy with darunavir/ritonavir plus raltegravir in HIV-infected patients with HIV-1 RNA ≤50 cp/mL
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits